NEW TOOL PROMISES BREAKTHROUGHS FOR HEP C
POTENTIAL BENEFITS FOR ALS, PARKINSON’S,
ALZHEIMERS, HUNTINGTON’S, MS, NEURODEGENERATIVE, HIV/AIDS, DIABETES, CANCER, RA, AND OTHER DISEASES
Oxygen is a significant and potent tool for the body’s defense against invading
foreign chemicals and organisms. The storage and release of oxygen form an integral
part of the immune system.
Oxygen transfers from red blood cells and concentrates into Reserve Oxygen (ROX) bundles. Unlike free oxygen, ROX bundles move in water, plasma and tissue. ROX bundles travel to and focus on the specific point of need, and then release oxygen at the site. The release of oxygen must be sharp and focused at the point of use. If less than a critical mass of ROX exists, ROX will not focus, and radicals will be released at the surrounding tissues, causing widespread damage. This can begin a chain of events leading to disease.
ROX (reserve oxygen capacity) is the measure of these oxygen reserves available for
transfer to tissues and cells. BOX (booster oxygen capacity) is the rate of replenishing
these reserves. Together, ROX and BOX are an indication of the strength of the body’s
immune system and ability to fight disease. Normal ROX and BOX levels (i.e., 100)
indicate a well functioning immune system. A lack of adequate levels of ROX and BOX
leads to disease.
ROX and BOX are easily measured using an Immunogram™ Analyzer (patents
pending). The Immunogram™ quantifies the immune system and outputs two numbers
from patient blood samples: ROX™ (the amount of reserve oxygen supply) and BOX™
(the amount of booster oxygen capacity). Other valuable information is also derived for
each patient.
The Immunogram™ Analyzer indicates the strength of a patient’s immune system,
predicts a patient’s response to treatment, and identifies those patients most likely to
overcome the threat of disease. Immunograms quantitate the body’s ability to deliver
oxygen to cells and tissues for energy usage, immune response, and detoxification.
Parallel measurements of ROX and BOX with biomarkers can lead to better biomarker
selection and increased specificity.
Solmedx is currently in clinical studies, to predict non-responders to interferon treatment
for patients with Hepatitis C. Additional studies are planned for evaluation of patients
with Alzheimer’s, ALS, and other neurodegenerative diseases; Cancer; Diabetes; HIV/
AIDS, Huntington’s Disease, Parkinson’s Disease (PD), Rheumatoid Arthritis (RA) and
other auto-immune diseases; and Complex Regional Pain Syndrome (CRPS).
PATIENT OUTCOME
IMPROVE patient response by monitoring ROX and BOX levels DURING treatment.
MONITOR overall patient wellness or health during annual physical exams by observing
ROX and BOX levels.
PREDICT patient-specific responses to a drug or a treatment by obtaining ROX and
BOX levels PRIOR to treatment.
MEASURE patient sensitivity for specific drugs PRIOR to initiating treatment.
SCREEN new drugs for toxicity using the Immunogram™ Analyzer in conjunction with
MedX™ Drug Standards.
Run an Immunogram Panel to get patient immune ‘fingerprints’
Parallel measurement of ROX and BOX with biomarkers can lead to better biomarker
selection and increased specificity.
 Download Immunogram™ Brochure
|
